期刊文献+

六味安消胶囊治疗老年人功能性便秘的临床研究 被引量:14

A clinical controlled study of Liuwei-Anxiao capsules for functional constipation in old patients
下载PDF
导出
摘要 目的评价六味安消胶囊治疗老年人慢性功能性便秘的临床治疗效果。方法采用随机双盲对照方法,观察66例老年人功能性便秘患者治疗前后排便次数、大便性状、排便困难症状评分、胃肠传输时间。结果六味安消胶囊组排便困难症状人均评分由治疗前基线期11.15±0.65下降为治疗后3.45±0.48(P<0.05),对照组分别为10.45±0.55和8.6±0.28(P>0.05);六味安消胶囊组治疗前后平均钡条残留率分别为68%±6%和40%±3%(P<0.05),对照组治疗前后平均钡条残留率分别为69%±5%和46%±6%(P<0.05)。结论六味安消胶囊能增加老年人功能性便秘患者的排便次数、改变大便性状、加快胃肠传输时间,有较好的安全性和耐受性。 Objective To evaluate the therapeutic effect of Liuwei-Anxiao capsules for functional constipation in elderly. Methods Randomized double-blind control study was applied to observe the defecate frequencies, stool property and constipation symptom grade in 66 old patients with functional constipation treated by Liuwei-Anxiao capsules and placebo respectively. Gastrointestinal motility function was tested by gastrointestinal transit time before and after treatment. Results Constipation symptom grade were reduced from 11.15±0.65 to 3.45±0.48 (P〈 0.05) in LiuweiAnxiao capsules treatment group. Average barium bar left rates were 68%±6% and 40%±3% (P〈0.05) before and after treatment ,respectively. Conclusions Liuwei-Anxiao capsules can decrease average barium bar left rates in old patients with functional constipation, increase defecate frequencies and gastrointestinal transit time, and change stool property. The recipe is safe and well tolerated.
出处 《解放军保健医学杂志》 2007年第1期18-20,共3页 Journal Of Health Care And Medicine in Chinese Pla
关键词 功能性便秘 药物疗法 胃肠传输时间 六味安消胶囊 functional constipation drug therapy gastrointestinal transit time Liuwei-Anxiao capsules
  • 相关文献

参考文献5

二级参考文献15

  • 1郭晓峰,柯美云,潘国宗,韩少梅,方秀才,鲁素彩,郭慧平.北京地区成年人慢性便秘流行病学调查及其相关因素分析[J].基础医学与临床,2001,21(z1):106-107. 被引量:112
  • 2Drossman DA. The functional gastrointestinal disorders and the RomeⅡprocess.Gut,1999,45(Suppl 2):Ⅱ1-Ⅱ5
  • 3Stark MK. Challenging problems presenting as constipation. Am J Gastroenterol, 1999, 94: 567-574.
  • 4Ruth M , Finizia C , Cange L , et al . The effect of mosapride on oesophageal motor function and acid reflux in patients with gastrooesophageal reflux disease. Eur J Gastroenterol Hepatol,2003, 15:1115-1121.
  • 5Hallerback BI, Bommelaer G, Bredberg E, et al. Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther, 2002, 16:959-967.
  • 6Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders, and functional abdominal pain . Gut, 1999,45 ( suppl Ⅱ ):Ⅱ43-Ⅱ47.
  • 7Inui A, Yoshikawa T, Nagai R, et al. Effects of mosapride citrate, a 5-HT(4) receptor agonist, on colonic motility in conscious guinea pigs. Jpn J Pharmacol,2002, 90:313-320.
  • 8Ji SW, Park HJ, Cho JS, et al. Investigation into the effects of mosapride on motility of Guinea pig stomach, ileum, and colon. Yonsei Med J,2003, 44:653-664.
  • 9戴菲,龚均.慢性便秘患者精神心理因素的研究[J].中国肛肠病杂志,2000,20(1):13-14. 被引量:98
  • 10周丽雅,夏志伟,林三仁,王惠吉,于中麟,黄乃侠,吕宗舜,胡伏莲,陈宝雯,王化虹.聚乙二醇4000治疗成人慢性功能性便秘的多中心随机对照临床试验研究[J].中国临床药理学杂志,2001,17(1):7-10. 被引量:56

共引文献155

同被引文献176

引证文献14

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部